CONCIERGE MEDICINE
MARCH 2025
MARCH 2025
Concierge medicine is a membership-based healthcare model in which patients pay an annual fee for enhanced access and personalized services from their physicians. By maintaining a smaller patient base, these practices can offer more dedicated attention, timely appointments, and a comprehensive approach to each individual’s health. This model fosters stronger, trust-based relationships between doctors and patients, ensuring care that is not only thorough but also tailored to unique needs and preferences.
Physicians operating under a concierge medicine model in the U.S. (2022)
Estimated annual membership fee range for concierge medicine service plans (2024)
Typical member-to-physician ratio in a standard concierge medicine practice setting (2024)
Typical member-to-physician ratio in a premium concierge medicine practice setting (2024)
Average patient retention rates in concierge medicine versus roughly 70%-80% in traditional practices
Fewer annual patients served through concierge medicine practices compared to traditional physician practices
Source: Publicly available information
The concierge model emphasizes a membership-based revenue structure and streamlined operations that enable personalized care but limit scalability, while traditional practices rely on insurance reimbursements and standardized processes, allowing for greater scalability through higher patient volumes.
Source: Publicly available information
The concierge medicine market in the U.S. is poised for significant growth, with a growing number of physicians exploring the concierge model as a solution to the structural challenges facing traditional practices. This shift reflects a trend toward more personalized, patient-centered care as doctors seek alternatives to conventional healthcare constraints.
The prominence of group practices in concierge medicine reflects a shift toward collaborative care, offering patients broader expertise and streamlined access. Emphasizing primary care, these practices focus on comprehensive, preventative health management and closer patient-provider relationships.
1. High burnout rates among providers are prompting doctors to seek improved work-life balance options
2. Increasing financial pressures and low reimbursements are making concierge fees increasingly appealing
3. Shifting consumer preferences have accelerated concierge medicine adoption among providers
Source: World Clinic, GM Insights, Publicly available information
Although there are signs of easing, physician burnout remains high, prompting some doctors to consider early retirement. The concierge model offers a solution by reducing patient loads, allowing for more manageable workloads, and promoting career longevity through a more balanced and sustainable practice environment.
The concierge medicine model addresses key factors contributing to physician burnout
Minimizes the administrative burden associated with third-party payors by relying on patient-paid fees, which reduces extensive documentation and compliance demands, allowing physicians to focus more on direct patient care and personalized services
Reduces panel size to 300-600 patients vs. 2000+ in traditional care, enabling personalized attention and shorter hours
Enhances professional autonomy by giving physicians greater control over treatment options, flexible scheduling, and personalized practice management, allowing care decisions to be driven by patient needs rather than insurance constraints
Source: Doximity, AMA, Publicly available information
Rising expenses, combined with declining and insufficient reimbursements, are squeezing profit margins for traditional practices. Despite seeing more patients, these financial pressures make it challenging to maintain profitability, positioning concierge medicine as an increasingly attractive alternative with its steady, membership-based revenue model.
The mounting pressures from reimbursement cuts and rising operational costs make traditional practice models increasingly unsustainable, prompting physicians to explore alternatives like concierge medicine. With its membership-based revenue structure, concierge medicine provides a stable income stream, reducing dependence on variable insurance payments and allowing physicians to focus more on patient care by minimizing administrative burdens.
Source: AHA, ASPE, Bain & Company Survey, Strata Comparative Analytics, Physician Flash Report, Publicly available information
1Medicare reimbursement rates
The shift toward personalized, patient-focused care is driving interest in concierge medicine, offering an alternative to traditional models by prioritizing accessibility, preventive health, and stronger physician-patient relationships.
By offering enhanced accessibility, preventive focus, and deeper patient-doctor relationships, concierge practices create a more satisfying and responsive healthcare experience. As a result, patients who can afford the premium fees are increasingly drawn to concierge care, valuing the tailored, proactive approach that traditional models often lack.
Source: Doximity, AMA, Publicly available information
The convergence of shifting consumer preferences, advancements in telehealth, and an aging population has further positioned concierge medicine as a solution that aligns with both patient preferences and healthcare provider needs. By offering tailored, preventive-focused services in a flexible and sustainable model, concierge medicine is well-equipped to address key challenges in healthcare today and drive long-term growth.
Source: AMA, HealthAffairs, Publicly available information
1% of healthcare visits in the U.S. (2020)
Concierge medicine operates within a complex regulatory framework, requiring careful attention to compliance in areas such as contractual obligations, insurance considerations, and federal and state laws to maintain transparency and patient trust.
Source: Publicly available information
While concierge medicine benefits the patients and providers within the model, it also presents challenges to the broader healthcare system, particularly by impacting accessibility, contributing to physician workforce shortages, and raising concerns about equitable care. As a result, ongoing monitoring of potential state and federal legislation will be crucial in shaping its future impact.
Regulatory discussions are centered on how to support innovation in concierge medicine while preventing unintended consequences that could further strain the healthcare system, ensuring that new models enhance care without reducing access or equity.
Source: Publicly available information
Date | Seller | Buyer | Type | Seller Summary |
---|---|---|---|---|
Dec-24 | Frontier Direct Care | Mehshah Capital, Health Advance Partners | PE Growth | DPC |
Oct-24 | HealthBridge | Pacific Lake | Platform | Concierge Medicine |
Jan-24 | Exemplar Care | Hy-Vee Health | M&A | DPC |
Nov-23 | Tequesta Family Medical Center | Medical Specialists of the Palm Beaches | Add-on | Concierge Medicine |
Nov-23 | Colton and Kaminetsky | Medical Specialists of the Palm Beaches | Add-on | Concierge Medicine |
Nov-23 | Nextera Healthcare | Shore Capital Partners | Buyout/LBO | DPC |
Sep-23 | Metzger Comprehensive Care | Medical Specialists of the Palm Beaches | Add-on | Concierge Medicine |
Hybrid models are allowing providers to integrate concierge patients into traditional practices, providing a gradual transition and financial stability.
Concierge practices are incorporating broader services, such as chronic care management as well as other physician specialties, to attract a wider range of patients and improve retention.
Growing awareness and acceptance of concierge medicine among patients and providers is driving accelerated adoption.
Increasing disposable incomes among key patient demographics provide a greater ability to afford personalized healthcare models.
The highly personalized nature of concierge medicine creates challenges in scaling operations without compromising patient experience.
While concierge medicine operates primarily outside traditional insurance, compliance with regulations and integration with other healthcare providers can present operational and legal hurdles.
Source: Publicly available information
Ownership: Markel Ventures
Investment Date: Jul 2011
Locations: 7
States: 4
No. Physicians: 25+
Ownership: Charlesbank Capital Partners, Goldman Sachs Asset Management
Investment Date: Oct 2021
Locations: 150+
States: 44
No. Physicians: 1,100+
Ownership: Private (Later Stage VC)
Locations: 55
States: 50
No. Physicians: 10+
Ownership: Resolute Capital Partners, Tenth Street Capital
Investment Date: Nov 2015
Locations: 40+
States: 18
No. Physicians: 11+
Ownership: Blue Sea Capital
Investment Date: Apr 2019
States: 35
No. Physicians: 200+
Ownership: Private
Locations: 2
States: 1
No. Physicians: 13+
Ownership: Private
Locations: 30+
States: 8
No. Physicians: 50+
Ownership: Private (Later Stage VC)
States: 19
No. Physicians: 50+
Source: Publicly available information
This document is being provided in connection with an actual or potential mandate or engagement and may not be used or relied upon for any purpose other than as specifically contemplated by a written agreement with the Allen, Mooney & Barnes companies. This document is intended solely for the use of the party to whom it was provided to and is not to be disclosed (in whole or in part), summarized, reprinted, sold, redistributed or otherwise referred to without the prior written consent of the AMB companies.
Allen Mooney & Barnes Brokerage Services is a broker/dealer member of FINRA and SIPC. Allen Mooney & Barnes Investment Advisors, Inc. is an investment adviser registered with the U.S. Securities and Exchange Commission.
Information presented in this document is for informational, educational and illustrative purposes only. While the information in this document is from sources believed to be reliable, the AMB companies make no representations or warranties, express or implied, as to whether the information is accurate or complete and assume no responsibility for independent verification of such information. In addition, the analyses in this document are narrowly focused and are not intended to provide a complete analysis of any matter.
Past performance is not necessarily indicative of future performance. Estimates, projections or indications of future performance can be identified by certain statements, such as "believes," "expects," "may," "will," "should," "seeks," "approximately," "plans," "estimates" or "anticipates" or the negative of those words or other comparable terminology, as well as by statements concerning projections, future performance, developments, events, revenues, expenses, earnings, run rates and any other guidance on present or future periods. Any such statements are forward-looking in nature and involve risks and uncertainties. Any statements of future performance are based on assumptions that might not be realized and a number of factors, including without limitation, the volatility of the securities markets, the overall environment for interest rates, risks associated with private equity investments, the demand for public offerings, activity in the secondary securities markets, competition among financial services firms for business and personnel, the effect of demand for public offerings, available technologies, the effect of government regulation and of general economic conditions on our own business and on the business in the industry areas on which we focus and the availability of capital to us. We are under no obligation to update the information presented in this document or to inform you if any such information turns out to be inaccurate or misleading.
The information in this document is not, and is not to be construed as, an offer or a solicitation to buy or sell any securities or any other financial instruments or a recommendation or endorsement to engage in or effect any particular investment or transaction. Moreover, under no circumstances should the information in this document be considered legal, tax or accounting advice or relied upon, therefore. The recipient is advised to rely on the advice of its own professionals and advisors for such matters and should make an independent analysis and decision regarding any transaction based upon such advice.
The information in this document is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or for any distribution or use that would subject the AMB companies to any registration requirement within such jurisdiction or country.
677 King Street, Suite 410 | Charleston, SC 29403
AMB focuses on lower middle-market healthcare niches where consumerism and fragmentation meet to disrupt traditional healthcare channels. We typically advise companies with EBITDA of $5M to $20M and an average enterprise value of $100M, but will move up and down the spectrum. AMB’s research-oriented approach to business development has resulted in a vast network of strategic and financial sponsor relationships that yield industry leading intelligence and optimal outcomes for our clients.
Managing Director
843-501-2183 Direct
mikel.parker@ambadvisors.com
Managing Director
843-405-1108 Direct
ryan.loehr@ambadvisors.com
Vice President
843-371-8596 Direct
johnny.cross@ambadvisors.com
Senior Associate
843-473-7981 Direct
kevin.williams@ambadvisors.com
Senior Associate
843-576-4709 Direct
sully.hagood@ambadvisors.com
Associate
843-405-1112 Direct
josh.hall@ambadvisors.com
Analyst
405-343-1643 Direct
asha.hamaker@ambadvisors.com
Analyst
843-271-5652 Direct
brayden.sarathy@ambadvisors.com